Medicare Enrolled
Dr. Karen Schwartz, M.D.
Internal Medicine · Woodbury, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schwartz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schwartz
Dr. Karen Schwartz is an internal medicine specialist in Woodbury, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schwartz performed 7,231 Medicare services across 4,031 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schwartz received a total of $318,878 from 74 pharmaceutical and/or device companies across 1430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schwartz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in NY
$318,878 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,231
Medicare services
Top 3% in NY for internal medicine
4,031
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~381 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,657 | $110 | $233 |
| Denosumab injection (Prolia/Xgeva) | 1,200 | $18 | $30 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
904 | $104 | $300 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
645 | $72 | $200 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
397 | $61 | $300 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
394 | $9 | $50 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
329 | $3 | $10 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
289 | $5 | $40 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
219 | $12 | $50 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
187 | $30 | $350 |
| Transvaginal pelvic ultrasound An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures. |
159 | $113 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
138 | $151 | $325 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
117 | $29 | $50 |
| New patient office visit, complex (60-74 min) | 102 | $191 | $371 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
90 | $16 | $50 |
| Pelvic and clinical breast exam for cancer screening A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider. |
86 | $47 | $75 |
| Pap smear screening test A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis. |
81 | $51 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $81 | $175 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
51 | $130 | $400 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
51 | $4 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $143 | $300 |
| Bone density scan (DEXA) of forearm, finger, hand, or foot A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture. |
17 | $38 | $200 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
16 | $60 | $100 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
14 | $134 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$318,878
Total received (2018-2024)
Avg $45,554/year across 7 years
Top 1% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
1,430
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$302,952 (95.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,926 (5.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$43,448
2023
$36,688
2022
$35,088
2021
$15,003
2020
$44,448
2019
$85,641
2018
$58,563
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$40,917
Astellas Pharma US Inc
$550
Amneal Pharmaceuticals LLC
$249
Abbott Laboratories
$207
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
Amgen Inc.
$188
Novo Nordisk Inc
$177
Bayer Healthcare Pharmaceuticals Inc.
$167
Radius Health, Inc.
$158
Xeris Pharmaceuticals, Inc.
$104
ABBVIE INC.
$80
MILLICENT US INC
$64
IBSA Pharma Inc.
$61
Dexcom, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$43
Tolmar, Inc.
$36
Esperion Therapeutics, Inc.
$31
Alexion Pharmaceuticals, Inc.
$30
Novartis Pharmaceuticals Corporation
$29
Mannkind Corporation
$25
PFIZER INC.
$25
BETA BIONICS, INC.
$22
Ascendis Pharma Inc
$18
Currax Pharmaceuticals LLC
$17
Top 3 companies account for 96.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$272,325
AMAG Pharmaceuticals, Inc.
$15,331
Astellas Pharma US Inc
$12,987
Insulet Corporation
$1,884
Novo Nordisk Inc
$1,696
Amneal Pharmaceuticals LLC
$1,485
Amgen Inc.
$1,404
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,293
Radius Health, Inc.
$1,133
SANOFI-AVENTIS U.S. LLC
$1,116
MannKind Corporation
$582
Abbott Laboratories
$528
AbbVie Inc.
$513
Mannkind Corporation
$408
Xeris Pharmaceuticals, Inc.
$378
Corcept Therapeutics
$300
AbbVie, Inc.
$268
Shire North American Group Inc
$251
Bayer Healthcare Pharmaceuticals Inc.
$247
MILLICENT US INC
$235
Merck Sharp & Dohme Corporation
$233
ABBVIE INC.
$229
TherapeuticsMD, Inc.
$228
Bayer HealthCare Pharmaceuticals Inc.
$214
Biohaven Pharmaceuticals, Inc.
$200
Dexcom, Inc.
$196
PFIZER INC.
$189
Janssen Pharmaceuticals, Inc
$187
IBSA Pharma Inc.
$183
Merz North America, Inc.
$175
Myovant Sciences Inc.
$173
Gemini Laboratories, LLC
$155
Vertical Pharmaceuticals, LLC
$144
OptiNose US, Inc.
$125
Horizon Therapeutics plc
$125
AstraZeneca Pharmaceuticals LP
$116
Intuity Medical Inc
$111
VIVUS, Inc.
$101
Medtronic, Inc.
$99
Regeneron Healthcare Solutions, Inc.
$90
Currax Pharmaceuticals LLC
$87
Amarin Pharma Inc.
$86
Sumitomo Pharma America, Inc.
$78
Alexion Pharmaceuticals, Inc.
$67
Becton, Dickinson and Company
$65
Medtronic MiniMed, Inc.
$62
Mission Pharmacal Company
$58
Novartis Pharmaceuticals Corporation
$56
Ultragenyx Pharmaceutical Inc.
$56
Valeritas, Inc.
$51
Alfasigma USA, Inc.
$42
Tolmar, Inc.
$36
Virtus Pharmaceuticals LLC
$34
Eisai Inc.
$34
Avion Pharmaceuticals
$34
Esperion Therapeutics, Inc.
$31
VistaPharm, Inc.
$26
Bigfoot Biomedical Inc
$26
MAYNE PHARMA INC.
$25
DERMIRA, INC.
$24
Duchesnay USA Incorporated
$24
Acella Pharmaceuticals, LLC
$22
BETA BIONICS, INC.
$22
VIVUS LLC
$21
Collegium Pharmaceutical, Inc.
$20
Antares Pharma, Inc.
$20
Kowa Pharmaceuticals America, Inc.
$20
Amryt Pharma Holdings Ltd
$19
Ascendis Pharma Inc
$18
Ascensia Diabetes Care US Inc.
$16
Exeltis, USA Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
Supernus Pharmaceuticals, Inc.
$14
EISAI INC.
$13
Top 3 companies account for 94.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ANNOVERA · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD Ultra-Fine · BIJUVA · Balcoltra · Belviq · Binosto · CONTRAVE · CRYSViTA · DIVIGEL · Dexcom CGM · Dexcom G6 Transmitter · Divigel · EVENITY · EVKEEZA · FARXIGA · FEMRING · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Femring · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · IMVEXXY · INTRAROSA · INVOKANA · InPen · Intrarosa · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · MYFEMBREE · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NP Thyroid 60 · NURTEC ODT · NovoLog · Omnipod · Osphena · Ozempic · PREMARIN · PROMETRIUM · Pogo Automatic Blood Glucose Monitoring System · Prolia · QBREXZA · QSYMIA · RECORLEV · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Slynd · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XEOMIN · XTAMPZA · XYOSTED · Xhance · Xultophy 100/3.6 · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in NY.
Geographic Context
Internal medicine physicians within 10 mi
5,915
Per 100K population
426.1
County median income
$143,408
Nearest hospital
PLAINVIEW HOSPITAL
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schwartz is a clinical cardiology specialist, with above-average Medicare volume (top 3% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schwartz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Schwartz performed 1,657 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwartz receive payments from pharmaceutical companies?
Yes. Dr. Schwartz received a total of $318,878 from 74 companies across 1,430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartz's costs compare to other internal medicine physicians in Woodbury?
Dr. Schwartz's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Woodbury
Browse internal medicine physicians in Woodbury ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AMAG Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from AMAG Pharmaceuticals, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology